Freeline, a UCL Technology Fund portfolio company has announced a $120m extended Series C financing from existing investors Syncona and new leading biotech funds. 

Read more

UCL Technology Fund has announced support for the research team at the UCL Cancer Institute.  The team are repurposing a sophisticated antibody engineering approach, to research and develop a new treatment against COVID-19. 

Read more

AlbionVC has led a £5.75m Series A round in TransFICC, joined by other investors from ING Ventures and HSBC.  

Read more

AstronauTx Ltd is a biotech company developing new medicines for the treatment of Alzheimer’s disease and other neurodegenerative diseases, announces £1 million investment from the UCL Technology Fund.

Read more

Echopoint Medical Ltd has raised £2.8m to develop optical sensing technology to help heart disease patients in a 'grey zone' where the need for treatment is unclear.

Read more

Elliptic raises $23 million in a Series B round led by Tokyo-based SBI Group

Read more

The UCL Technology Fund led a £750k investment into Phasecraft, a pioneering quantum computing company, along with co-investors Parkwalk Advisors and the London Co-Investment Fund.

Read more

UCLTF £1m investment into Quell Therapeutics is part of a £35m Series A round led by Syncona

Read more